{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:57:33Z","timestamp":1791413853832,"version":"4.3.3"},"reference-count":21,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.04.032","type":"book-chapter","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:12:39Z","timestamp":1748466759000},"source":"Crossref","is-referenced-by-count":3,"title":["Special populations in myasthenia gravis: Early, late, and very late-onset MG"],"prefix":"10.1016","author":[{"given":"Sarah","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.irn.2025.04.032_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.56.1.25","article-title":"Late-onset myasthenia gravis: A changing scene","volume":"56","author":"Aarli","year":"1999","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.032_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110564","article-title":"Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls","volume":"27","author":"Bhandage","year":"2024","journal-title":"iScience"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.032_bib3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10072-022-06519-5","article-title":"Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis","volume":"44","author":"Bi","year":"2023","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.032_bib4","first-page":"9839","article-title":"Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction","volume":"15","author":"Braun","year":"2024","journal-title":"Nature\u00a0Communications"},{"key":"10.1016\/bs.irn.2025.04.032_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.032_bib6","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: A genome-wide association study","volume":"119","author":"Chia","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.032_bib7","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1212\/WNL.0000000000008903","article-title":"Clinical and therapeutic features of myasthenia gravis in adults based on age at onset","volume":"94","author":"Cortes-Vicente","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.032_bib8","first-page":"1099","article-title":"Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin","volume":"73","author":"Cortes-Vicente","year":"2016","journal-title":"Journal of the American Medical Association Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.032_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","volume":"1412","author":"Cron","year":"2018","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.032_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.10.028","article-title":"Myasthenia gravis in the elderly","volume":"325","author":"Hellmann","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.032_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","article-title":"Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders","volume":"21","author":"Huijbers","year":"2022","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.032_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2019.02.016","article-title":"Results of robotic thymectomy performed in myasthenia gravis patients older than 60 years at onset","volume":"108","author":"Li","year":"2019","journal-title":"The Annals of Thoracic Surgery"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.032_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2011.03.004","article-title":"Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey","volume":"305","author":"Murai","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/bs.irn.2025.04.032_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s42466-020-00091-z","article-title":"Outcome measures and treatment effectiveness in late onset myasthenia gravis","volume":"2","author":"Pasqualin","year":"2020","journal-title":"Neurological Research and Practice"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.032_bib15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00415-019-09667-5","article-title":"Frequency and clinical features of treatment-refractory myasthenia gravis","volume":"267","author":"Rath","year":"2020","journal-title":"Journal of Neurology"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.032_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2010.10.023","article-title":"Clinical and immunological differences between early and late-onset myasthenia gravis in Japan","volume":"230","author":"Suzuki","year":"2011","journal-title":"Journal of Neuroimmunology"},{"issue":"20","key":"10.1016\/bs.irn.2025.04.032_bib17","first-page":"2006","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.032_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11910-013-0421-9","article-title":"Ocular myasthenia gravis: Controversies and updates","volume":"14","author":"Wong","year":"2014","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.032_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-titin antibodies in myasthenia gravis: Tight association with thymoma and heterogeneity of nonthymoma patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2025.04.032_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"Journal of Autoimmunity"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.032_bib21","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00415-012-6478-6","article-title":"Characteristics of late-onset myasthenia gravis","volume":"259","author":"Zivkovic","year":"2012","journal-title":"Journal of Neurology"}],"container-title":["International Review of Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:12:44Z","timestamp":1748466764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.04.032","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}